标题
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
作者
关键词
-
出版物
Nature Microbiology
Volume 5, Issue 10, Pages 1185-1191
出版商
Springer Science and Business Media LLC
发表日期
2020-09-10
DOI
10.1038/s41564-020-00789-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Bin Zhang et al. CHEST
- Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins
- (2020) Tommy Tsan-Yuk Lam et al. NATURE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Against pandemic research exceptionalism
- (2020) Alex John London et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
- (2020) Shufa Zheng et al. BMJ-British Medical Journal
- Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
- (2020) Kenrie P Y Hui et al. Lancet Respiratory Medicine
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- Viral dynamics in mild and severe cases of COVID-19
- (2020) Yang Liu et al. LANCET INFECTIOUS DISEASES
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model
- (2019) Anwar M Hashem et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics
- (2019) Katie L. Winarski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
- (2019) Andrew R. Crowley et al. Frontiers in Immunology
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
- (2018) Carlos A. Sariol et al. TRENDS IN MICROBIOLOGY
- Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
- (2018) Fan Luo et al. VIROLOGICA SINICA
- Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
- (2018) Matthew S. Parsons et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
- (2017) Taia T. Wang et al. SCIENCE
- Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
- (2016) David J. DiLillo et al. JOURNAL OF CLINICAL INVESTIGATION
- Vaccines against respiratory syncytial virus: The time has finally come
- (2016) Barney S. Graham VACCINE
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Influenza-Specific Antibody-Dependent Phagocytosis
- (2016) Fernanda Ana-Sosa-Batiz et al. PLoS One
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
- (2014) A. Hiatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
- (2014) Fumihiko Yasui et al. VIROLOGY
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
- (2014) Ming Yip et al. Virology Journal
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
- (2013) Jie Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Adverse effects of plasma transfusion
- (2012) Suchitra Pandey et al. TRANSFUSION
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway
- (2011) M. Jaume et al. JOURNAL OF VIROLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started